Painreform Ltd Total Assets
Painreform Ltd total assets. Based on the latest financial reports, Painreform Ltd (PRFX) holds total assets worth $11.16 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Painreform Ltd (PRFX) market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Painreform Ltd (2017–2024)
Total assets of Painreform Ltd from 2017 to 2024. This chart illustrates how Painreform Ltd's total assets have evolved over time, based on quarterly financial data. See PRFX stock price and chart for real-time trading data and today's change.
Painreform Ltd - Asset Composition Analysis
Painreform Ltd Total Assets Breakdown (December 2024)
Painreform Ltd total assets breakdown as of December 2024. Painreform Ltd's total assets of $11.16 Million consist of 97.9% current assets and 2.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 94.2% |
| Accounts Receivable | $119.00K | 2.6% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Painreform Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Painreform Ltd current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Painreform Ltd's current assets represent 97.9% of total assets in 2024, a decrease from 99.5% in 2017.
- Cash Position: Cash and equivalents constituted 94.2% of total assets in 2024, up from 87.4% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 2.6% of total assets.
Painreform Ltd Competitors by Total Assets
Key competitors of Painreform Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Painreform Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.59 | 1.81 | 18.51 |
| Quick Ratio | 1.59 | 1.81 | 18.51 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.45 Million | $1.99 Million | $16.83 Million |
Painreform Ltd - Advanced Valuation Insights
This section examines the relationship between Painreform Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.28 |
| Latest Market Cap to Assets Ratio | 0.32 |
| Asset Growth Rate (YoY) | -54.4% |
| Total Assets | $4.53 Million |
| Market Capitalization | $1.47 Million USD |
Valuation Analysis
Below Book Valuation: The market values Painreform Ltd's assets below their book value (0.32x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Painreform Ltd's assets decreased by 54.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Painreform Ltd (2017–2024)
The table below shows the annual total assets of Painreform Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.53 Million | -54.43% |
| 2023-12-31 | $9.93 Million | -19.45% |
| 2022-12-31 | $12.33 Million | -35.36% |
| 2021-12-31 | $19.07 Million | +7.15% |
| 2020-12-31 | $17.80 Million | +1429.30% |
| 2019-12-31 | $1.16 Million | +1337.04% |
| 2018-12-31 | $81.00K | -62.15% |
| 2017-12-31 | $214.00K | -- |
About Painreform Ltd
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinica… Read more